<DOC>
	<DOC>NCT01243671</DOC>
	<brief_summary>To investigate efficacy, safety and pharmacokinetics of adalimumab subcutaneous (sc) for Japanese subjects with intestinal Behçet's disease who are refractory to conventional therapies.</brief_summary>
	<brief_title>A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease</brief_title>
	<detailed_description />
	<mesh_term>Behcet Syndrome</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Intestinal Behçet's disease Patients with typical ulcer at ileocecal region Patients who have failed conventional treatment Crohn's disease History of ileocecal resection History of tuberculosis (TB) Female subject who is pregnant or breastfeeding or considering becoming pregnant during the study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Behçet's, intestinal</keyword>
</DOC>